Gestational diabetes & diabetes in pregnancy

Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial

JAMAPublished Randomised controlled trial

Primary result · Infants born large for gestational ageResult — go to the resultAbsolute risk difference 4.0% 95% CI −1.7% to 9.8%

Authors' conclusion

Treatment of gestational diabetes with metformin and additional glyburide, if needed, did not meet criteria for noninferiority compared with insulin with respect to the proportion of infants born large for gestational age.

Study context

Population
Individuals with GDM and singleton pregnancies at 16–34 weeks of gestation with insufficient glycemic control after 2 weeks of dietary changes; 25 Dutch centers, June 2016–November 2022; mean age 33.2 (SD, 4.7) years
Participants
820 individuals
Comparison
Oral glucose-lowering agents vs insulin
  • Oral agentsn = 409
  • Insulinn = 411reference
Primary endpoint
Between-group difference in the percentage of infants born large for gestational age (birth weight >90th percentile for gestational age and sex)
Methodological detailsopen-label, noninferiority, multicentre (25 Dutch centers)
  • Open-label
  • Noninferiority
  • Multicentre (25 Dutch centers)

Primary result

Infants born large for gestational age

Absolute risk difference

4.0%

95% CI −1.7% to 9.8%

P = 0.09 for noninferiority

Events by treatment group

Oral agentsvs Insulin
absolute risk difference 4.0% (95% CI −1.7% to 9.8%); P = 0.09 for noninferiority

As reported in the abstract

Secondary outcomes

Glycemic control maintained without insulin (oral agents) — Oral agents
79%

Other secondary outcomes (cesarean delivery, pregnancy-induced hypertension, preeclampsia, maternal weight gain, preterm delivery, birth injury, neonatal hypoglycemia, neonatal hyperbilirubinemia, neonatal ICU admission)

All other secondary outcomes did not differ between groups

Safety

OutcomeOral agentsInsulinAbsolute risk difference (95% CI)
Maternal hypoglycemia20.9%10.9%10.0% (3.7%–21.2%)

Original publication

Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial. JAMA. Published 11 February 2025. doi:10.1001/jama.2024.23410

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.